Healthcare stocks are facing steep losses as several names have either manufacturing facilities in the tariffed countries and ...

A recap of the most heavily shorted stocks on the ASX and those experiencing significant changes to short interest over the ...

Welcome back to the Insider Trades Series – A weekly summary of on-market ASX director transactions valued at more than ...

Apple (-0.6%) 1Q25 EPS beat, with gross margins 40 bps above estimates, iPhone revenue missed by ~2%, Mac and iPad ...

See Upcoming Dividends for all ASX companies.

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits) ...

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits) ...

Full-year EBITDA guidance cut to $11-14 million vs. prior guidance of $11-16 million (7.4% downgrade at the midpoint) Full-year revenue guidance cut to $260-270 million vs. prior guidance of $280-290 ...

ResMed (ASX: RMD) posted a solid December quarter, with most figures slightly exceeding market expectations, driven by strong device growth. US device growth: “Global device sales were driven by ...

For a detailed explanation of Carl's technical analysis methodology, be sure to check out this ChartWatch Primer. Carl has over 30-year's investing experience, helping investors navigate several bull ...

IBM (+13.0%) beats forecasts amid surge in AI software and consulting revenue, Q2 EPS of $3.92 was well-ahead of $3.78 consensus (BBG) Tesla (+2.8%) Q4 profit misses on weaker-than-expected gross ...